Teknimed
PrivateLast Round
Buyout/LBO
Jul 2, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Teknimed operates in Healthcare & Life Sciences and is based in Toulouse. It was founded in 1990.
Teknimed is a biotechnology company that develops, manufactures, and distributes orthopaedic bone cements, synthetic bone substitutes, and other biomaterials for surgical applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Teknimed Comparables
Compare Teknimed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OSARTIS GmbH | 87% | |
| Biocomposites | 86% | |
| Tecres | 85% |
For institutional investors. Book with your work email.
Teknimed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Buyout/LBO | Jul 2, 2026 | ||||
| Buyout/LBO | Nov 9, 2021 | ||||
| Buyout/LBO | Jun 1, 2015 |
For institutional investors. Book with your work email.
Teknimed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bourrelier Group | Buyout/LBO |
| Seven2 | Buyout/LBO |
| Apheon | Buyout/LBO |
| Bpifrance | Buyout/LBO |
| Multicroissance | Buyout/LBO |
| Crédit Mutuel Equity | Buyout/LBO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2026
Apheon led the buyout round.
- Nov 9, 2021
Essling Expansion led the round with participation from Bourrelier Group and Multicroissance.
For institutional investors. Book with your work email.
Teknimed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Teknimed's valuation, stock price, and market status.
Is Teknimed a public or private company?
Teknimed is a private company.
What is the current stock price of Teknimed?
Teknimed is a private company, so its shares have no public market price. Caplight tracks Teknimed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Teknimed worth (valuation)?
Valuation information for Teknimed is not publicly available.
Can I buy Teknimed stock?
Teknimed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Teknimed's last funding round?
Teknimed's most recent funding round was Buyout/LBO on July 2, 2026.
Who are the main investors in Teknimed?
Key investors in Teknimed include Seven2, Apheon.
Will Teknimed IPO soon?
No public IPO plans have been announced for Teknimed.
How can I track Teknimed secondary market activity?
Caplight tracks bids, offers, and trades in Teknimed's shares on secondary markets.